Association between changes in loop diuretic dose and outcomes in acute heart failure

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Acute heart failure (AHF) management often involves loop diuretics.
• The impact of initiating or adjusting loop diuretic doses during AHF hospitalization on long-term outcomes remains unclear.

Purpose of the Study:

• To investigate the association between initiating or modifying loop diuretic therapy during AHF hospitalization and post-discharge mortality.
• To examine the relationship between loop diuretic dosage at discharge and patient outcomes.

Main Methods:

• Analysis of 3665 patients from the Kyoto Congestive Heart Failure registry hospitalized for heart failure.
• Comparison of outcomes for patients who started loop diuretics versus those who did not.
• Assessment of dose adjustments (decreased, unchanged, increased) in patients already on loop diuretics.

Main Results:

• Initiating loop diuretics during AHF hospitalization showed no significant association with post-discharge mortality (aHR 0.92, 95% CI 0.68-1.25).
• Loop diuretic dose changes during hospitalization were not linked to altered post-discharge mortality risk compared to no change.
• A discharge loop diuretic dose of ≥80 mg was associated with a higher risk of post-discharge mortality.

Conclusions:

• Initiating loop diuretics during AHF hospitalization does not appear to influence post-discharge mortality.
• Loop diuretic dose modifications during AHF hospitalization do not significantly affect post-discharge outcomes.
• Higher loop diuretic doses at discharge may be associated with increased post-discharge mortality risk in AHF patients.